Aveanna Healthcare AVAH
$11.01 +$0.31 (+2.90%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $11.12 +1.00%
Open$10.72
Prev close$10.70
Day range$10.65 – $11.03
Volume2.17M
Market cap$2.40B
P/E (TTM)7.9
Dividend yield–
Earnings
Average move on report day±14.2%last 16 reports
Closed higher11 of 1669% of the time
Best reaction+49.4%
Worst reaction-8.2%
Stock move on the day after each report
| Quarter | Report date | Timing | Implied move | Actual move | Versus implied |
|---|---|---|---|---|---|
| 2026/Q3 | 12 Nov 2026 | Pre Market | ±11.9% | -6.49% | Within range |
| 2026/Q2 | 13 Aug 2026 | Pre Market | ±17.1% | +24.75% | Bigger than priced |
| 2026/Q1 | 14 May 2026 | Pre Market | ±13.3% | +9.90% | Within range |
| 2025/Q4 | 19 Mar 2026 | Pre Market | ±17.4% | -8.25% | Within range |
| 2025/Q3 | 6 Nov 2025 | Pre Market | ±25.8% | -6.30% | Within range |
| 2025/Q2 | 7 Aug 2025 | Pre Market | – | +49.36% | – |
| 2025/Q1 | 8 May 2025 | Pre Market | ±17.6% | +14.11% | Within range |
| 2024/Q4 | 13 Mar 2025 | Pre Market | ±73.5% | +37.43% | Within range |
| 2024/Q3 | 7 Nov 2024 | Pre Market | ±23.5% | +16.22% | Within range |
| 2024/Q2 | 8 Aug 2024 | Pre Market | ±70.0% | +32.22% | Within range |
| 2024/Q1 | 9 May 2024 | Pre Market | ±16.5% | +2.48% | Within range |
| 2023/Q4 | 14 Mar 2024 | Pre Market | ±12.0% | -3.00% | Within range |
| 2023/Q3 | 9 Nov 2023 | Pre Market | ±104.7% | +2.01% | Within range |
| 2023/Q2 | 10 Aug 2023 | None | ±64.8% | +3.41% | Within range |
| 2023/Q1 | 11 May 2023 | Pre Market | ±112.4% | +3.81% | Within range |
| 2022/Q4 | 16 Mar 2023 | Pre Market | ±57.7% | -6.71% | Within range |
"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.
Where the revenue comes from
Quarter 2026/Q3
By business line
Fundamentals
Latest reported quarter: Q3, ended Oct 2026
Revenue$695.54M+11.8% YoY
Operating profit$84.22M+60.7% YoY
Net profit$45.45M+223.2% YoY
Diluted EPS$0.20+233.3% YoY
Free cash flow$70.34M+125.6% YoY
Operating cash flow$72.25M
Revenue, last 8 quarters
Net profit, last 8 quarters
Profitability & balance sheet
Gross margin32.3%
Operating margin11.7%
Net margin11.4%
Return on equity175.9%
Return on assets15.2%
Return on invested capital21.8%
Current ratio1.23
Liabilities / assets84.7%
Cash & investments$197.84M
Total debt$1.53B
Net cash (debt)-$1.33B
Free cash flow / sales7.4%
No comments yet — be the first to weigh in on AVAH.
Sign in to join the discussion.